Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2010-03-31
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ATEM
A prospective one-arm non-interventional study with asthma patients treated with Alvesco.
Alvesco
This is an observational study. Therefore, the physician decides about dosage according to individual needs.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Alvesco
This is an observational study. Therefore, the physician decides about dosage according to individual needs.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Other criteria as defined in the Summary of Product Characteristics, Chapter 4.3
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AstraZeneca AstraZeneca
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nycomed Pharma GmbH
Amstetten, , Austria
Nycomed Pharma GmbH
Baden, , Austria
Nycomed Pharma GmbH
Bludenz, , Austria
Nycomed Pharma GmbH
Böhlerwerk, , Austria
Nycomed Pharma GmbH
Braunau am Inn, , Austria
Nycomed Pharma GmbH
Bregenz, , Austria
Nycomed Pharma GmbH
Dornbirn, , Austria
Nycomed Pharma GmbH
Enns, , Austria
Nycomed Pharma GmbH
Feldbach, , Austria
Nycomed Pharma GmbH
Feldkirch, , Austria
Nycomed Pharma GmbH
Furth, , Austria
Nycomed Pharma GmbH
Gföhl, , Austria
Nycomed Pharma GmbH
Gr. Siegharts, , Austria
Nycomed Pharma GmbH
Graz, , Austria
Nycomed Pharma GmbH
Graz, , Austria
Nycomed Pharma GmbH
Graz, , Austria
Nycomed Pharma GmbH
Graz, , Austria
Nycomed Pharma GmbH
Graz-Gösting, , Austria
Nycomed Pharma GmbH
Groß-Gerungs, , Austria
Nycomed Pharma GmbH
Gunskirchen, , Austria
Nycomed Pharma GmbH
Güssing, , Austria
Nycomed Pharma GmbH
Haag, , Austria
Nycomed Pharma GmbH
Hall in Tirol, , Austria
Nycomed Pharma GmbH
Hallein, , Austria
Nycomed Pharma GmbH
Hartberg, , Austria
Nycomed Pharma GmbH
Herzogenburg, , Austria
Nycomed Pharma GmbH
Innsbruck, , Austria
Nycomed Pharma GmbH
Judenburg, , Austria
Nycomed Pharma GmbH
Kaltenbach, , Austria
Nycomed Pharma GmbH
Kirchdorf and Der Krems, , Austria
Nycomed Pharma GmbH
Kitzbühel, , Austria
Nycomed Pharma GmbH
Klein-Pöchlam, , Austria
Nycomed Pharma GmbH
Landeck, , Austria
Nycomed Pharma GmbH
Leibnitz, Styria, , Austria
Nycomed Pharma GmbH
Lenzing, , Austria
Nycomed Pharma GmbH
Linz, , Austria
Nycomed Pharma GmbH
Linz, , Austria
Nycomed Pharma GmbH
Linz, , Austria
Nycomed Pharma GmbH
Litschau, , Austria
Nycomed Pharma GmbH
Mank, , Austria
Nycomed Pharma GmbH
Melk, , Austria
Nycomed Pharma GmbH
Mittersill, , Austria
Nycomed Pharma GmbH
Mödling, , Austria
Nycomed Pharma GmbH
Mühldorf, , Austria
Nycomed Pharma GmbH
Münster, , Austria
Nycomed Pharma GmbH
Neumarkt am Wallersee, , Austria
Nycomed Pharma GmbH
Niederkreuzstetten, , Austria
Nycomed Pharma GmbH
Pasching, , Austria
Nycomed Pharma GmbH
Pinkafeld, , Austria
Nycomed Pharma GmbH
Pucking, , Austria
Nycomed Pharma GmbH
Saint Johann I. Pg., , Austria
Nycomed Pharma GmbH
Salzburg, , Austria
Nycomed Pharma GmbH
Sankt Pölten, , Austria
Nycomed Pharma GmbH
Schlüsslberg, , Austria
Nycomed Pharma GmbH
Schörfling, , Austria
Nycomed Pharma GmbH
Schwanenstadt, , Austria
Nycomed Pharma GmbH
St.Georgen i.A., , Austria
Nycomed Pharma GmbH
Steyr, , Austria
Nycomed Pharma GmbH
Strallegg, , Austria
Nycomed Pharma GmbH
Sulz, , Austria
Nycomed Pharma GmbH
Thalheim bei Wels, , Austria
Nycomed Pharma GmbH
Traisen, , Austria
Nycomed Pharma GmbH
Traismauer, , Austria
Nycomed Pharma GmbH
Vienna, , Austria
Nycomed Pharma GmbH
Vienna, , Austria
Nycomed Pharma GmbH
Vienna, , Austria
Nycomed Pharma GmbH
Vienna, , Austria
Nycomed Pharma GmbH
Vienna, , Austria
Nycomed Pharma GmbH
Vienna, , Austria
Nycomed Pharma GmbH
Vienna, , Austria
Nycomed Pharma GmbH
Vienna, , Austria
Nycomed Pharma GmbH
Vienna, , Austria
Nycomed Pharma GmbH
Voitsberg, , Austria
Nycomed Pharma GmbH
Waidhofen/Thaya, , Austria
Nycomed Pharma GmbH
Weitra, , Austria
Nycomed Pharma GmbH
Wiener Neustadt, , Austria
Nycomed Pharma GmbH
Wilhelmsburg, , Austria
Nycomed Pharma GmbH
Ysper, , Austria
Nycomed Pharma GmbH
Zwettl Stadt, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CL-9709-401-DE
Identifier Type: -
Identifier Source: org_study_id